Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Red yeast rice is supported by scientific evidence for its use in managing aspects of Metabolic Syndrome, primarily due to its cholesterol-lowering properties. Red yeast rice is produced by fermenting rice with the yeast Monascus purpureus, which produces monacolin K, a compound chemically identical to the statin drug lovastatin. Several clinical trials have shown that red yeast rice supplementation can significantly lower total cholesterol and LDL cholesterol levels, both of which are key components of Metabolic Syndrome. Some studies also suggest modest benefits in reducing triglycerides and improving overall lipid profiles.

For example, a meta-analysis published in the American Journal of Cardiology (2012) found that red yeast rice reduced LDL cholesterol by an average of 1.02 mmol/L compared to placebo. Additionally, a 2015 review in the Journal of Clinical Lipidology concluded that red yeast rice is effective and generally well-tolerated in patients with mild to moderate hypercholesterolemia.

However, while red yeast rice has a strong tradition of use in Chinese medicine for promoting circulation and digestive health, the evidence specifically supporting its use for the broader cluster of Metabolic Syndrome (which includes hypertension, insulin resistance, and abdominal obesity) is less robust. Most clinical evidence focuses on lipid management rather than the full syndrome. Therefore, while red yeast rice is a scientifically validated adjunct for dyslipidemia—a component of Metabolic Syndrome—its effects on the complete syndrome remain under investigation.

More about red yeast rice
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by red yeast rice

Products containing red yeast rice

Nature's Sunshine Red Yeast Rice